Timentin Powder For Solution For Injection 30-1G Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Timentin: Powder for solution for injection (30-1g)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

TICARCILLIN, CLAVULANIC ACID (tye kar SILL in, KLAV yoo la nate AS id) is a penicillin antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

In-Depth Information

Timentin 31g Bulk Powder for Injection

NDC: 000296579
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Bacteremia, Pneumonia, Peritonitis, Gynecologic Infections, Intraabdominal Infections, Septicemia, Bone And Joint Infections, Skin And Skin Structure Infections, Urinary Tract Infection (UTI), Endometritis, Lower Respiratory Tract Infections

Sometimes used for but not FDA approved for the following conditions:
Febrile Neutropenia, Pericarditis, Cystic Fibrosis

Storage Information
Discard product if it contains particulate matter, is cloudy, or discolored
Store unreconstituted product at or below 75 degrees F
Protect from freezing
Avoid excessive heat (above 104 degrees F)
Timentin 31g Bulk Powder for Injection

Reported Side Effects for Timentin 31g Bulk Powder for Injection

Bleeding Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Hemolysis Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Low Potassium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Painful Bloody Urine Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Superinfection Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Feeling Sick Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Chills Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Muscle Pain Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Pseudomembranous Colitis Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Hives Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Serum Sickness Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Metallic Taste Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Mouth Ulcers Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Timentin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5